logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Complement And Kidney Disease 1st Edition Momir Macanovic Peter Lachmann Auth

  • SKU: BELL-4287078
Complement And Kidney Disease 1st Edition Momir Macanovic Peter Lachmann Auth
$ 31.00 $ 45.00 (-31%)

5.0

50 reviews

Complement And Kidney Disease 1st Edition Momir Macanovic Peter Lachmann Auth instant download after payment.

Publisher: Birkhäuser Basel
File Extension: PDF
File size: 3.71 MB
Pages: 236
Author: Momir Macanovic, Peter Lachmann (auth.), Peter F. Zipfel (eds.)
ISBN: 9783764371661, 9783764374280, 3764371668, 3764374284
Language: English
Year: 2006
Edition: 1

Product desciption

Complement And Kidney Disease 1st Edition Momir Macanovic Peter Lachmann Auth by Momir Macanovic, Peter Lachmann (auth.), Peter F. Zipfel (eds.) 9783764371661, 9783764374280, 3764371668, 3764374284 instant download after payment.

It is evident that a defective or deregulated complement system results in kidney diseases. An important role of complement effector and regulatory proteins in pathological settings of the kidney has been demonstrated. A large panel of distinct human kidney diseases is caused by defective complement control. Genetic analyses have identified mutations in complement regulators that are associated with these diseases. Mutations have been identified in the fluid phase alternative pathway regulator Factor H and the membrane regulator Membrane Cofactor Protein MCP (CD46). The functional characterization of the mutant proteins allows to define the pathophysiological events on a molecular level. These new concepts and data on disease mechanisms allowed establishing new diagnostic and promising therapeutic approaches for several human kidney diseases. Molecular biology, clinics and therapy are discussed in this volume.

Related Products